CD163 and neoplasm: Positivity for iNOS, CD163, and IDO1 was detected in a subset of tumour-associated macrophages (TAMs), while iNOS and IDO1 positivity was also seen in a subset (83% and 20%, respectively) of tumour cells (Fig. 1).